Free Trial
Final Hours! Save $100 on MarketBeat All Access Before 11:59 PM
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149 Tonight
Claim MarketBeat All Access Sale Promotion

Oric Pharmaceuticals (ORIC) Stock Forecast & Price Target

Oric Pharmaceuticals logo
$8.32 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$8.64 +0.32 (+3.89%)
As of 05/22/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Oric Pharmaceuticals - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
1
Hold
2
Buy
12

Based on 15 Wall Street analysts who have issued ratings for Oric Pharmaceuticals in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 15 analysts, 1 has given a sell rating, 2 have given a hold rating, and 12 have given a buy rating for ORIC.

Consensus Price Target

$19.36
132.74% Upside
According to the 15 analysts' twelve-month price targets for Oric Pharmaceuticals, the average price target is $19.36. The highest price target for ORIC is $25.00, while the lowest price target for ORIC is $15.00. The average price target represents a forecasted upside of 132.74% from the current price of $8.32.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for ORIC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Oric Pharmaceuticals and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ORIC Analyst Ratings Over Time

TypeCurrent Forecast
5/25/25 to 5/25/26
1 Month Ago
4/25/25 to 4/25/26
3 Months Ago
2/24/25 to 2/24/26
1 Year Ago
5/25/24 to 5/25/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
12 Buy rating(s)
11 Buy rating(s)
11 Buy rating(s)
8 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
0 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$19.36$19.90$20.10$19.17
Forecasted Upside132.74% Upside94.34% Upside49.78% Upside201.84% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyBuy

ORIC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ORIC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Oric Pharmaceuticals Stock vs. The Competition

TypeOric PharmaceuticalsMedical CompaniesBroader Market
Consensus Rating Score
2.73
2.30
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside132.74% Upside1,718.96% Upside15.09% Upside
News Sentiment Rating
Neutral News

See Recent ORIC News
Neutral News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
5/22/2026
Cantor Fitzgerald logo
Cantor Fitzgerald
5 of 5 stars
 Reiterated RatingOverweight
5/15/2026UpgradeNeutralBuy$15.00+79.86%
5/5/2026
Citigroup Inc. logo
Citigroup
4 of 5 stars
Yigal Nochomovitz
4 of 5 stars
Lower TargetBuy$17.00 ➝ $16.00+72.73%
4/21/2026 Reiterated RatingSell (D-)
4/2/2026Reiterated RatingBuy$25.00+234.67%
4/1/2026Lower TargetOutperform$20.00 ➝ $17.00+34.18%
2/24/2026Reiterated RatingOutperform$15.00+28.10%
1/7/2026Initiated CoverageOverweight$22.00+170.27%
12/8/2025Boost TargetOverweight$19.00 ➝ $25.00+127.27%
11/20/2025Initiated CoverageOutperform$25.00+117.77%
11/18/2025Boost TargetOverweight$17.00 ➝ $20.00+70.95%
11/18/2025Initiated CoveragePeer Perform
9/4/2025Initiated CoverageBuy$18.00+69.81%
8/12/2025 UpgradeHold
7/8/2025Initiated CoverageBuy$15.00+40.85%
9/6/2024 Initiated CoverageBuy$20.00+110.97%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 01:00 PM ET.


ORIC Forecast - Frequently Asked Questions

According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Oric Pharmaceuticals is $19.36, with a high forecast of $25.00 and a low forecast of $15.00.

15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Oric Pharmaceuticals in the last twelve months. There is currently 1 sell rating, 2 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ORIC shares.

According to analysts, Oric Pharmaceuticals's stock has a predicted upside of 132.74% based on their 12-month stock forecasts.

Over the previous 90 days, Oric Pharmaceuticals's stock had 1 upgrade by analysts.

Oric Pharmaceuticals has been rated by research analysts at Cantor Fitzgerald, Citigroup, HC Wainwright, Oppenheimer, The Goldman Sachs Group, Wedbush, and Weiss Ratings in the past 90 days.

Analysts like Oric Pharmaceuticals more than other "medical" companies. The consensus rating for Oric Pharmaceuticals is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how ORIC compares to other companies.


This page (NASDAQ:ORIC) was last updated on 5/25/2026 by MarketBeat.com Staff.
From Our Partners